RxDoctor Payments Data

Adam Henson

Family Medicine · du Quoin, ILNPI 1154684975

Payments from drug & device makers

$6,603in general payments, 2019–2025

Across 468 payments — averaging $14.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$991
  • Lilly USA, LLC$942
  • Pfizer$793
  • AstraZeneca$654
  • AbbVie$527
  • GSK$316
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$6,583100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,603 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$24,707
Medicare patients
155
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$55,896
JardianceEmpagliflozin32$34,793
RybelsusSemaglutide13$29,379
OzempicSemaglutide17$21,597
JanuviaSitagliptin Phosphate24$20,962
Repatha SureclickEvolocumab33$20,657
MyrbetriqMirabegron33$16,342
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$16,079
TrulicityDulaglutide14$13,254
FarxigaDapagliflozin Propanediol13$12,773
TrintellixVortioxetine Hydrobromide14$9,701
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,135
MovantikNaloxegol Oxalate18$7,201
Spiriva HandihalerTiotropium Bromide13$6,324
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen152$3,714

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$793$55,89673 claims
Novo NordiskRybelsus, Ozempic$991$50,97630 claims
Boehringer IngelheimJardiance$143$34,79332 claims
AstraZenecaFarxiga, Breztri Aerosphere$654$21,90825 claims
MerckJanuvia$81$20,96224 claims
GSKTrelegy Ellipta$316$16,07927 claims
Lilly USA, LLCTrulicity$942$13,25414 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$60$9,70114 claims
AbbVieSynthroid$527$59216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in du Quoin

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →